CardiacSense Ltd
 | |
| Industry | Medical products |
|---|---|
| Founded | 2009 |
| Founder |
|
| Headquarters | Caesarea , Israel |
| Products | Wearables, medical device technology, heart arrythmias, blood pressure |
Number of employees | 40 |
| Website | www |
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring.[1] CardiacSense is based in Caesarea, Israel.[2][3][4]
Overview
CardiacSense Ltd is a private limited company founded in 2009 as Sportracker.[5] The company formerly developed a device for tracking heart rate readings during sport activities. In 2015 the company changed its name to CardiacSense and refocused activities on medical devices.[3] CardiacSense's devices monitor heart rate for the purpose of detecting heart disorders such as atrial fibrillation tachycardia, bradycardia, PVCs, PACs, pause, and cardiac arrest. The device comes in the form of a wristwatch.[5][2] It monitors heart rate (HR), heart rate variabilities (HRV), respiratory rate, blood pressure (continuously and cuff-less)[5] as well as measures oxygen saturation (SpO2) and body temperature, skin temperature, and additional vital signs.[6][3][4]
The watch can monitor and detect sleep apnea as well as Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) patients’ health condition deterioration.[citation needed]
Technology
CardiacSense technology combines Electrocardiogram (ECG) and Photoplethysmography (PPG) sensors along with a unique mechanics, optics and algorithm.[2][3] The PPG is an optical sensing technique that measures changes in fluid (blood) volume. The company developed a proprietary optical solution as well as an artifact sensor that improve the accuracy by eliminating all movement artifacts that effects the PPG sensor.[3] The device has a continuous monitoring capability. In case of an Arrhythmia, such as Atrial Fibrillation, the watch alerts the user and send messages to the patient's physician. The user's data is saved in the watch memory and uploaded to a cloud application via the user's cellular device.
In the United States, the watch will be issued by a prescription and the physician can choose if and when to be notified.[7]
In Europe and rest of the world, the watch will not require a prescription.
CardiacSense completed its first clinical trial at the Tel Aviv Sourasky Medical Center in 2016.[5][3] Since then CardiacSense completed different multi-site clinical trials at the Tel Aviv Sourasky Medical Center, The Rambam Health Care Campus in Haifa and The Sheba Medical Center in Ramat Gan and in UCSF. The company is planning a series of new clinical trials in Israel and in the United States for respiratory rate, sleep apnea, oxygen saturation and blood pressure.[citation needed]
Capitalization
CardiacSense has raised ~25M$ million to date (May 2022). Rounds were: ~2M$ in (2010-2016), ~6.7M$ in [8](2017-2019), ~6.7M$ in (2019–2020),[2][9] ~10M$ in (2021-2022).
Regulatory
Cardiacsense Medical Watch has CE Mark for continuous HR, HRV, Atrial Fibrillation.[2][4] detection and spot one lead ECG. FDA clearance is in process.
References
- ^ Zhang; Berthelot; Lo (October 2016). Wireless wearable photoplethysmography sensors for continuous blood pressure monitoring. IEEE. doi:10.1109/wh.2016.7764560. ISBN 9781509030903.
{{cite book}}:|journal=ignored (help) - ^ a b c d e "Heart Monitoring Company CardiacSense Raises Funds to License Device". CTECH - www.calcalistech.com. 2018-05-27. Retrieved 2018-07-23.
- ^ a b c d e f "ECGs on the move, thanks to Israeli ingenuity". Israel21c. Retrieved 2018-07-23.
- ^ a b c "New health trackers warn of heart-attack risk, discreetly". USA TODAY. Retrieved 2018-07-23.
- ^ a b c d "Israeli medical watch co CardiacSense raises $500,000 - Globes". Globes (in Hebrew). Retrieved 2018-07-23.
- ^ "לאן הלך הכסף? כל הגיוסים והאקזיטים הישראלים של חודש נובמבר". גיקטיים (in Hebrew). 2017-12-02. Retrieved 2018-07-23.
- ^ "קארדיאק סנס הישראלית מגייסת 700 אלף דולר מקליבלנד קליניק האמריקנית". אנשים ומחשבים - פורטל חדשות היי-טק, מיחשוב, טלקום, טכנולוגיות (in Hebrew). 2017-10-03. Retrieved 2018-07-23.
- ^ "קארדיאק-סנס הישראלית מגייסת 750 אלף דולר לפיתוח שעון שיתריע על התקפי לב". גיקטיים (in Hebrew). 2017-11-05. Retrieved 2018-07-23.
- ^ "Israeli medical watch co CardiacSense raises $500,000 | FirstWord MedTech". www.firstwordmedtech.com. Retrieved 2018-07-23.